|
⚲
|
| Keyboard |
| Aviragen Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0000072444 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0000072444] | |
| 10-Q | [0000072444] | |
| 3 | [0000072444] | |
| 4 | [0000072444] | |
| 8-K | [0000072444] | |
| SC 13D | [0000072444] | |
| SC 13G | [0000072444] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Watson W Mark | |
| NABI Biopharmaceuticals | |
| Grasman Jeroen Nicolaas | |
| Breitmeyer James B | |
| Cummings James F | |
| Tucker Sean | |
| Berg Edward B | |
| Lo Steven | |
| Heron Elaine J | |
| Finney Kevin | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-28 | Tax withheld | 3,924 | $0.65 | 2,551 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-28 | Tax withheld | 3,292 | $0.65 | 2,140 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-24 | Tax withheld | 36,418 | $0.69 | 25,128 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-24 | Tax withheld | 126,028 | $0.69 | 86,959 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-24 | Tax withheld | 30,551 | $0.69 | 21,080 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-24 | Tax withheld | 36,418 | $0.69 | 25,128 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-18 | Tax withheld | 6,772 | $0.63 | 4,266 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-18 | Tax withheld | 8,072 | $0.63 | 5,085 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-18 | Tax withheld | 8,072 | $0.63 | 5,085 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-18 | Tax withheld | 22,425 | $0.63 | 14,128 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 200,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 225,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 227,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 227,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 455,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 455,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 1,543,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 846,500 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 115,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||